Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil Hydroworld Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Iveric Bio Inc (NQ: ISEE ) N/A UNCHANGED Last Price Updated: 4:00 PM EDT, Jul 10, 2023 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings All News about Iveric Bio Inc < Previous 1 2 3 4 5 6 7 8 9 Next > Iveric Bio Shares Shoot Higher Following Positive Top-line Data From Late-Stage Geographic Atrophy Study September 06, 2022 Iveric Bio (NASDAQ: ISEE) announced positive topline results from the second Phase 3 clinical trial of Zimura (avacincaptad pegol) for the treatment of geographic atrophy (GA). Via Benzinga 12 Health Care Stocks Moving In Tuesday's Pre-Market Session September 06, 2022 Via Benzinga IVERIC bio Stock Soars After Encouraging Geographic Atrophy Trial Data September 06, 2022 IVERIC bio Inc (NASDAQ: ISEE) announced positive data from the second Phase 3 trial of Zimura (avacincaptad pegol) for geographic atrophy (GA). Via Benzinga Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday September 06, 2022 Good morning, trader! It's time to start off the day with a breakdown of the biggest pre-market stock movers for Tuesday morning! Via InvestorPlace What 5 Analyst Ratings Have To Say About IVERIC bio August 02, 2022 Within the last quarter, IVERIC bio (NASDAQ:ISEE) has observed the following analyst ratings: Via Benzinga IVERIC bio Shares Jump On Debt Financing To Fund Zimura Launch July 26, 2022 Via Benzinga Recap: IVERIC bio Q2 Earnings July 26, 2022 IVERIC bio (NASDAQ:ISEE) reported its Q2 earnings results on Tuesday, July 26, 2022 at 07:00 AM. Here's what investors need to know about the announcement. Via Benzinga Iveric Bio Announces Positive Topline Data from Zimura® GATHER2 Phase 3 Clinical Trial in Geographic Atrophy September 06, 2022 From IVERIC bio, Inc. Via Business Wire Iveric Bio Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) September 02, 2022 From IVERIC bio, Inc. Via Business Wire 12 Health Care Stocks Moving In Thursday's Intraday Session August 25, 2022 Via Benzinga Earnings Scheduled For July 26, 2022 July 26, 2022 Companies Reporting Before The Bell • General Motors (NYSE:GM) is likely to report quarterly earnings at $1.30 per share on revenue of $34.59 billion. Via Benzinga Short Volatility Alert: IVERIC bio, Inc. July 21, 2022 On Wednesday, shares of IVERIC bio, Inc. (NASDAQ: ISEE) experienced volatile short activity. After the activity, the stock price went up +1.70% to $11.95. The overall sentiment for ISEE has been... Via Benzinga Expert Ratings for IVERIC bio July 07, 2022 IVERIC bio (NASDAQ:ISEE) has observed the following analyst ratings within the last quarter: Via Benzinga Why Several Chinese Stocks Traded Higher; Here Are 58 Biggest Movers From Yesterday August 26, 2022 Gainers Kiora Pharmaceuticals, Inc. (NASDAQ: KPRX) surged 95.3% to close at $0.2580 on Thursday after Ladenburg Thalmann initiated coverage on the stock with a Buy rating and announced a price target... Via Benzinga 10 Health Care Stocks Whale Activity In Today's Session August 17, 2022 This whale alert can help traders discover the next big trading opportunities. Whales are entities with large sums of money and we track their transactions here at Benzinga on our options activity... Via Benzinga Iveric Bio to Participate in the H.C. Wainwright 2nd Annual Ophthalmology Virtual Conference August 10, 2022 From IVERIC bio, Inc. Via Business Wire 7 Cheap Biotech Stocks to Buy Now August 03, 2022 These cheap biotech stocks to buy offer investors a way to get ready for the inevitable comeback in the biopharmaceutical sector. Via InvestorPlace Iveric Bio to Present at the Wedbush PacGrow Healthcare Conference 2022 August 03, 2022 From IVERIC bio, Inc. Via Business Wire Benzinga's Top Ratings Upgrades, Downgrades For August 2, 2022 August 02, 2022 Upgrades Via Benzinga Iveric Bio Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) August 02, 2022 From IVERIC bio, Inc. Via Business Wire 3 Biotech Stock Picks From This Wedbush Analyst July 27, 2022 While the S&P 500 index peaked in January and has had a rough year, the biotech sector peaked last August. For the time being, both have found a short-term and possible long-term bottom in June. Via Benzinga Daily Biotech Pulse: EU Approval For AbbVie's Ulcerative Colitis Treatment, Angion Biomedica Evaluates Alternatives, Clinical Hold For Immuron's Bacterial Infection Candidate July 26, 2022 Here's a roundup of top developments in the biotech space over the last 24 hours: Via Benzinga Alibaba, General Electric And Some Other Big Stocks Moving Higher In Today's Pre-Market Session July 26, 2022 Redbox Entertainment Inc. (NASDAQ: RDBX) rose 11.5% to $6.19 in pre-market trading after jumping 82% on Monday. Via Benzinga Iveric Bio Reports Second Quarter 2022 Operational Highlights and Financial Results July 26, 2022 From IVERIC bio, Inc. Via Business Wire Iveric Bio Announces Agreement for Up to $250 Million in Non-Dilutive Debt Financing with Hercules Capital and Silicon Valley Bank July 26, 2022 From IVERIC bio, Inc. Via Business Wire Earnings Preview: IVERIC bio July 25, 2022 IVERIC bio (NASDAQ:ISEE) is set to give its latest quarterly earnings report on Tuesday, 2022-07-26. Here's what investors need to know before the announcement. Analysts estimate that IVERIC bio will... Via Benzinga Iveric Bio to Report Second Quarter 2022 Financial Results and Host Conference Call on Tuesday, July 26, 2022 July 21, 2022 From IVERIC bio, Inc. Via Business Wire Iveric Bio Announces Post-Hoc Analysis from GATHER1 Clinical Trial of Zimura® at American Society of Retina Specialists Meeting July 16, 2022 From IVERIC bio, Inc. Via Business Wire The Daily Biotech Pulse: AstraZeneca Goes Shopping, TYME Technologies & Syros Pharma Merger, FDA Clears Vertex Pharma's Stem Cell-Based Diabetes Therapy Study July 05, 2022 Here's a roundup of top developments in the biotech space over the last 24 hours: Via Benzinga Iveric Bio and DelSiTech Enter Exclusive Agreement for Development of Sustained Release Zimura® July 05, 2022 From IVERIC bio, Inc. Via Business Wire < Previous 1 2 3 4 5 6 7 8 9 Next > Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.
